<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03689803</url>
  </required_header>
  <id_info>
    <org_study_id>FirstJinanU20180214</org_study_id>
    <nct_id>NCT03689803</nct_id>
  </id_info>
  <brief_title>the Related Factors of Bariatric Surgery on Lipidemia</brief_title>
  <official_title>The Impact of Bariatric Surgery on Estimated Lipidemia in Chinese Obesity Patients: a Retrospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital of Jinan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital of Jinan University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obesity and related metabolic diseases have become a chronic disease that is a threat to
      human health. Bariatric surgery can effectively and long-term reduce excess body weight and
      relieve related metabolic diseases, including type 2 diabetes. Laparoscopic gastric bypass
      surgery and laparoscopic sleeve gastrectomy are commonly used in bariatric surgery.
      Laparoscopic sleeve gastrectomy due to simple operation, good weight loss, and metabolic
      disease control effect, which is more widely used. However, there are several studies that
      show an increased chance of gastroesophageal reflux disease after laparoscopic sleeve
      gastrectomy. Long-term gastroesophageal reflux may lead to Barrett's esophagus or esophageal
      cancer. Nowadays, the cause of gastroesophageal reflux disease after sleeve gastrectomy is
      not clear and precautionary measures are not precise.

      In this study, prospective randomized controlled trials were conducted to explore the
      possible change of lipidemia after bariatric surgery and to explore ways to prevent bariatric
      surgery after bariatric surgery.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>preoperative of choleaterol</measure>
    <time_frame>Preoperate</time_frame>
    <description>choleaterol in ml/dl</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative of choleaterol at 3 months</measure>
    <time_frame>3 months</time_frame>
    <description>choleaterol in ml/dl</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative of choleaterol at 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>choleaterol in ml/dl</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative of choleaterol at 1 year</measure>
    <time_frame>1 year</time_frame>
    <description>choleaterol in ml/dl</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Preoperative of triglyceride</measure>
    <time_frame>Preoperative</time_frame>
    <description>triglyceride in ml/dl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative of triglyceride at 3 months</measure>
    <time_frame>3 months</time_frame>
    <description>triglyceride in ml/dl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative of triglyceride at 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>triglyceride in ml/dl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative of triglyceride at 1 year</measure>
    <time_frame>1 year</time_frame>
    <description>triglyceride in ml/dl</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">1000</enrollment>
  <condition>Bariatric Surgery</condition>
  <condition>Lipidemia</condition>
  <arm_group>
    <arm_group_label>Lipidemia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sleeve gastrectomy</intervention_name>
    <description>sleeve gastrectomy.</description>
    <arm_group_label>Lipidemia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>gastric bypass</intervention_name>
    <description>gastric bypass</description>
    <arm_group_label>Lipidemia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -For the choice of surgical approach, numerous studies have shown that BMI â‰§ 45, the
        general choice of gastric bypass surgery, BMI &lt;45, you can choose sleeve gastrectomy. The
        remission rate for T2DM, sleeve gastrectomy has a good result for young patients with
        shorter duration. In the investigator's country, the BMI less than 45 is majorities.

        Exclusion Criteria:

        -BMI&lt;27.5
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The frist affiliated hospital of Jinan University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510630</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>June 3, 2018</study_first_submitted>
  <study_first_submitted_qc>September 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2018</study_first_posted>
  <last_update_submitted>September 26, 2018</last_update_submitted>
  <last_update_submitted_qc>September 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital of Jinan University</investigator_affiliation>
    <investigator_full_name>Jingge Yang</investigator_full_name>
    <investigator_title>Director of bariatric surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperlipidemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

